Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Medicamen Organics Ltd

Pharmaceuticals & Biotechnology | Small Cap

Medicamen Organics Ltd Health Insights
Health Score : 6.30Health Score : 6.30

Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Medicamen Organics Ltd Health Insights
Health Score : 6.30Health Score : 6.30

Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-9.16

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Highly Undervalued

Small Cap Median

27.17

Highly Undervalued

P/E RATIO

-6.94

P/B RATIO

0.97

Highly Undervalued

Industry Median

3.17

Highly Undervalued
Highly Undervalued

Small Cap Median

2.62

Highly Undervalued

P/S RATIO

1.26

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

-7.73

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹22.9 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 9.20

The growth ratios indicate strong growth. High revenue growth, operating profit growth, EPS growth, and net income growth rates suggest the company is expanding its business and increasing its profitability. The asset growth rate, however, is concerning. Overall, the company is experiencing robust growth in key areas, indicating positive momentum and future potential.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2024Mar 2025Mar 2026
Revenue Growth Rate51.13-40.74
Operating Profit Growth Rate39.45-156.73
Earnings Per Share (EPS) Growth13.44-195.38
Asset Growth Rate54.03-12.8
Net Income Growth Rate54.58-199.26
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The financial ratios present a mixed outlook. While capital expenditures are well-managed, the adjusted EPS, cash EPS, book value per share, and dividend per share suggest areas needing improvement. The company's earnings per share and book value are relatively low, and it does not currently pay dividends. Capital expenditures are being managed effectively. There are some areas requiring concern.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)1.883.46-3.3
Cash Earnings Per Share (Cash EPS)3.884.09-2.56
Book Value Per Share17.7425.7523.55
Dividend Per Share (DPS)000
Capital Expenditures (CapEx)0.32.51.7
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.60

The profitability ratios look strong. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin suggest the company is generating profits efficiently and effectively. The company is performing well in terms of profitability, indicating sound financial health and potential for future growth. Overall, the company is doing good in profitability.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
AverageReturn on Assets (ROA)Average
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2024Mar 2025Mar 2026
Gross Profit Margin15.9115.37-20.55
Return on Capital Employed (ROCE)33.0116.88-10.66
Return on Equity (ROE)17.1713.44-13.99
Return on Assets (ROA)12.3311.16-7.26
Operating Margin18.7617.31-16.57
Net Margin10.3710.6-17.76
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.67

Efficiency ratios presents a mixed picture. While the days sales in inventory is efficient, the fixed asset turnover, inventory turnover, receivables turnover, receivable days, and capital turnover ratios suggest areas where the company could improve its operational efficiency. The company may be facing challenges in converting assets into sales and managing its working capital effectively. Enhancing efficiency can lead to improved profitability and better resource utilization.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.443.771.69
Inventory Turnover Ratio3.464.743.03
Receivables Turnover Ratio1.511.81.02
Days Sales in Inventory Ratio105.4977120.46
Receivable Days241.21202.78357.84
Capital Turnover Ratio1.641.260.76
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The coverage ratios suggest a good ability to meet its interest obligations but some difficulties in covering equity dividends. The solid interest coverage ratio indicates the company can comfortably pay its interest expenses. The equity dividend coverage ratio raises concerns about the company's ability to cover dividend payments with its equity. Overall, the company is in a reasonable position to manage its debt obligations.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2024Mar 2025Mar 2026
Interest Coverage Ratio7.8311.06-6.44
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.50

The solvency position looks strong. The company exhibits a very low debt ratio and debt-to-equity ratio, indicating minimal reliance on debt financing. A high equity ratio further supports this, reflecting a strong equity base. The negligible debt-to-asset ratio suggests that the company's assets are primarily financed by equity, reducing financial risk. Overall, the company is in a financially stable position with low leverage.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
GoodEquity RatioGood
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2024Mar 2025Mar 2026
Debt Ratio0.0100.04
Debt to Equity Ratio0.0100.04
Equity Ratio0.9910.96
Debt To Asset Ratio000.02
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 3.36

The liquidity position reveals that the company may face challenges in meeting its short-term obligations. While the quick ratio indicates some ability to cover immediate liabilities, the current and cash ratios raise concerns about overall liquidity. The negative operating cash flow ratio further exacerbates these concerns, suggesting potential difficulties in generating cash from core operations. The company needs to improve its short-term financial health.

PoorCurrent RatioPoor
AverageQuick RatioAverage
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2024Mar 2025Mar 2026
Current Ratio1.211.621.75
Quick Ratio0.951.361.27
Cash Ratio0.020.140.06
Operating Cash Flow Ratio-0.16-0.16-0.21
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 7 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medicamen Organics Ltd6.30-6.94Neutral-3.75-2.50-4.02
2Mono Pharmacare Ltd6.166.26Neutral8.001.753.00
3JFL Life Sciences Ltd6.079.43Neutral12.001.946.00
4Walpar Nutritions Ltd5.299.26Neutral6.662.093.00
5Mangalam Drugs and Organics Ltd4.50-1.07Neutral-15.00-27.68-44.00
6Lasa Supergenerics Ltd4.39-2.61Highly Undervalued-7.00-6.80-34.00
7Sunrest Lifescience Ltd4.177.06Highly Undervalued10.213.608.00
Management Assessment Summary
OrangeBalanced Management

The management of Medicamen Organics Ltd. exhibits a mixed performance. The company shows significant revenue growth, with a 51% increase in sales, and a 55% compounded profit growth. However, the declining Operating Profit Margin (OPM) and high cash conversion cycle raise concerns about operational efficiency. Overall, the management demonstrates strengths in driving revenue and profit growth but needs to address operational efficiency and working capital management.

Category Metric Value Assessment
PROS Sales Growth 51% Strong revenue expansion
Profit Growth 55% Strong profit growth
CONS OPM % 17.23% Declining OPM
Cash Conversion Cycle 175.39 Days High Cash Conversion Cycle
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Medicamen Organics is rated Orange, indicating moderate risk. The primary concerns arise from the company's extended cash conversion cycle, which ties up working capital. The high number of debtor days is a concern. However, the company’s sales and profit growth indicate positive momentum. This mixed risk profile suggests that while the company has growth potential, it also faces challenges that require careful management.

ExcellentAccounting quality red flagsExcellent
01.

Accounting quality red flags

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1022.56Bullish
  3. SMA 2022.24Bullish
  4. SMA 5020.99Bullish
  5. EMA 1022.55Bullish
  6. EMA 2022.18Bullish
  7. EMA 5021.65Bullish
  8. DEMA 1022.88Bullish
  9. DEMA 2022.85Bullish
  10. DEMA 5021.74Bullish
  11. TEMA 1022.85Bullish
  12. TEMA 2023.02Bearish
  13. TEMA 5022.69Bullish
  14. MACD0.49Bullish
  15. ADX31.63Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI62.71Neutral
  3. CCI82.86Neutral
  4. ROC 91.55Bullish
  5. ROC 146.51Bullish
  6. ROC 257.26Bullish
  7. Stoch K82.17Overbought
  8. Stoch D73.47Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper23.47Neutral
  3. BB Middle22.24Neutral
  4. BB Lower21.01Neutral
  5. ATR0.29Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI87.84Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1022.35Bullish
  3. SMA 2021.54Bullish
  4. SMA 5021.14Bullish
  5. EMA 1022.30Bullish
  6. EMA 2021.79Bullish
  7. EMA 5021.87Bullish
  8. DEMA 1022.91Bearish
  9. DEMA 2022.40Bullish
  10. DEMA 5020.83Bullish
  11. TEMA 1023.00Bearish
  12. TEMA 2023.06Bearish
  13. TEMA 5021.39Bullish
  14. MACD0.51Bullish
  15. ADX22.00Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI63.68Neutral
  3. CCI110.54Overbought
  4. ROC 96.51Bullish
  5. ROC 1411.71Bullish
  6. ROC 259.83Bullish
  7. Stoch K88.89Overbought
  8. Stoch D79.73Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper23.46Neutral
  3. BB Middle21.54Neutral
  4. BB Lower19.61Neutral
  5. ATR0.41Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI63.93Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1021.56Bullish
  3. SMA 2020.95Bullish
  4. SMA 5023.19Bearish
  5. EMA 1021.87Bullish
  6. EMA 2021.69Bullish
  7. EMA 5022.81Bullish
  8. DEMA 1022.53Bullish
  9. DEMA 2021.28Bullish
  10. DEMA 5020.89Bullish
  11. TEMA 1023.15Bearish
  12. TEMA 2022.16Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.14Bullish
  15. ADX20.47Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI58.54Neutral
  3. CCI140.81Overbought
  4. ROC 912.53Bullish
  5. ROC 1414.50Bullish
  6. ROC 256.02Bullish
  7. Stoch K95.12Overbought
  8. Stoch D97.56Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper23.14Neutral
  3. BB Middle20.95Neutral
  4. BB Lower18.76Neutral
  5. ATR0.65Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI81.94Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1020.89Bullish
  3. SMA 2022.20Bullish
  4. SMA 5025.16Bearish
  5. SMA 10024.61Bearish
  6. SMA 20029.07Bearish
  7. EMA 1021.64Bullish
  8. EMA 2022.43Bullish
  9. EMA 5023.99Bearish
  10. EMA 10025.38Bearish
  11. EMA 20029.80Bearish
  12. DEMA 1021.33Bullish
  13. DEMA 2020.77Bullish
  14. DEMA 5022.51Bullish
  15. DEMA 10022.33Bullish
  16. DEMA 20020.08Bullish
  17. TEMA 1022.15Bullish
  18. TEMA 2020.41Bullish
  19. TEMA 5021.85Bullish
  20. TEMA 10023.17Bearish
  21. TEMA 200N/AN/A
  22. MACD-1.16Bullish
  23. ADX17.46Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI49.65Neutral
  3. CCI13.17Neutral
  4. ROC 14-4.58Bearish
  5. ROC 25-13.75Bearish
  6. Stoch K63.95Neutral
  7. Stoch D44.23Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper26.04Neutral
  3. BB Middle22.20Neutral
  4. BB Lower18.35Neutral
  5. ATR1.21High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI22.49Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2025.00Bearish
  3. SMA 5029.67Bearish
  4. EMA 2025.18Bearish
  5. EMA 5030.63Bearish
  6. DEMA 2023.04Bearish
  7. DEMA 5020.18Bearish
  8. TEMA 2023.52Bearish
  9. TEMA 50N/AN/A
  10. MACD-1.62Bearish
  11. ADX16.65Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI36.05Neutral
  3. CCI-121.30Oversold
  4. ROC 14-11.01Bearish
  5. ROC 25-23.02Bearish
  6. Stoch K15.79Oversold
  7. Stoch D27.66Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper31.13Neutral
  3. BB Middle25.00Neutral
  4. BB Lower18.86Neutral
  5. ATR3.08Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.11Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

No results for this timeframe.

No results for this timeframe

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 624.79Bearish
  3. SMA 1230.55Bearish
  4. SMA 2443.26Bearish
  5. EMA 626.12Bearish
  6. EMA 1231.32Bearish
  7. EMA 2443.26Bearish
  8. DEMA 623.46Bullish
  9. DEMA 1220.67Bullish
  10. DEMA 24N/AN/A
  11. TEMA 624.74Bearish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADXN/AN/A
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSIN/AN/A
  3. CCIN/AN/A
  4. ROC 25N/AN/A
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper54.94Neutral
  3. BB Middle34.32Neutral
  4. BB Lower13.70Neutral
  5. ATR12.25Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI45.29Neutral